HK Stock Market Move | SSY GROUP (02005) once rose over 5%, with a nearly 13% year-on-year increase in net profit for the first half of the year, and an opposite trend growth in the sales volume of infused solutions.

date
13:45 26/08/2026
avatar
GMT Eight
Stone Fourth Pharmaceutical Group (02005) rose over 5% in the afternoon, and as of the time of publication, it was up 4.37%, priced at HKD 2.625, with a trading volume of HKD 20.6154 million.
SSY GROUP (02005) saw a rise of over 5% in the afternoon, and as of press time, it rose 4.37% to HK$2.625, with a trading volume of HK$20.6154 million. In terms of news, SSY GROUP announced its mid-term performance for 2026 during the noon session, reporting revenue of HK$2.361 billion for the first half of the year, a year-on-year increase of 9.94%; net profit attributable to shareholders was HK$320 million, up 12.99% year-on-year; basic earnings per share were HK$0.1107, and the company proposed an interim dividend of HK$0.055 per share. Looking at specific business segments, the sales volume of infusion products achieved countercyclical growth in the first half of the year, reaching 868 million bottles (or bags), a year-on-year increase of 21.4%; revenue amounted to HK$1.487 billion, a 24.0% increase compared to the same period last year. In the water injection business, sales reached HK$163 million, a year-on-year increase of 3.5%; oral preparations generated sales of HK$165 million, a decrease of 44% year-on-year; and raw materials achieved sales of HK$395 million, a year-on-year increase of 9.4%.